No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Unusual Options Activity: WBD, BNTX and Others Attract Market Bets, WBD V/OI Ratio Reaches 921.1
Morgan Stanley Maintains BioNTech(BNTX.US) With Hold Rating, Maintains Target Price $101
Morgan Stanley Sticks to Its Hold Rating for BioNTech SE (BNTX)
Andreas & Thomas Struengmann Award Honors HAYA Therapeutics Co-founders as Inaugural Winners
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading
Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod